workshop the science and methodologies behind hta, diversity and commonality across the eu
DESCRIPTION
Workshop The science and methodologies behind HTA, diversity and commonality across the EU. Achieving more patient centred HTA in different countries. Terminology. Patients Citizens Public Service users etc. Rationale for HTA. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/1.jpg)
WorkshopThe science and methodologies
behind HTA, diversity and commonality across the EU
Achieving more patient centred HTA in different countries
![Page 2: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/2.jpg)
Terminology
• Patients
• Citizens
• Public
• Service users– etc
![Page 3: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/3.jpg)
Rationale for HTA
• There are increasing expectations of what healthcare is available/provided
• Increasing demands on available budgets
• Decisions on what should be made available should be rational based on all available evidence
![Page 4: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/4.jpg)
Health Technology Assessment (HTA)
• HTA is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner
![Page 5: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/5.jpg)
Different types of HTA
• Assessment of available evidence to clarify the way a technology should be used
• Assessment of available evidence to determine whether there is enough evidence to support the use of a technology
• Assessment of available evidence of effectiveness and cost effectiveness to determine whether a technology offers value for money
![Page 6: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/6.jpg)
Evidence used in HTA
• Clinical trials– Efficacy– Quality of life
• Economic evaluations
• Modelling
![Page 7: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/7.jpg)
Clinical trials
• Get involved in the design of clinical trials so they measure what is important to patients
• Ensure trial populations are broadly relevant
• Help put the results of trials into the context of a patient’s life
![Page 8: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/8.jpg)
Health related quality of life
• Help develop and test QOL tools so they reflect what matters to patients
• Try to ensure that disease specific tools are developed and validated– Reflect changes in priorities for patients at
different stages of illness
• Think about carers quality of life
![Page 9: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/9.jpg)
Economic evaluations
• Cost– Incremental cost effectiveness ratio (ICER)– Cost utility analysis
• Cost per quality adjusted life year (QALY)
– Disability adjusted life year (DALY)
![Page 10: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/10.jpg)
How is patient evidence incorporated into HTA?
• Patient input to trials
• Patient input to assessment reports
• Patient evidence
• Reviewing recommendations
• Making recommendations available in plain language
![Page 11: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/11.jpg)
Challenges of involving patients in research
• Challenges experienced by patients• Contribution hindered by difficulties with access
and communication• Relationship (doctor supremacy, fear of
preferential care)• Tokenism (political correctness)• Anxieties of new role – unclear about role and
ability to contribute, perceived value of contribution, not appearing foolish, lack of familiarity with technical terms
Hewlett et al, 2006
![Page 12: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/12.jpg)
Patient evidence
• Quantitative– Questionnaires/surveys– Patient Organisation databases
• Qualitative– Individual interviews– Focus groups discussions and interviews– Futures workshops– Blogs, etc
![Page 13: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/13.jpg)
Patient perspective
• Use research that is
• – well planned and structured
• – systematic
• – reported clearly showing sources, methods, potential biases, assumptions and findings
![Page 14: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/14.jpg)
3 fundamental issues affecting theme
![Page 15: Workshop The science and methodologies behind HTA, diversity and commonality across the EU](https://reader036.vdocument.in/reader036/viewer/2022072013/56812c28550346895d909d50/html5/thumbnails/15.jpg)
3 core recommendations